Resverlogix (RVX) Competitors C$0.04 -0.01 (-12.50%) As of 05/2/2025 12:11 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesBuy This Stock RVX vs. GSD, AEZS, LTY, BCT, ACST, REUN, NEPT, ATE, SBM, and HEMShould you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include Devonian Health Group (GSD), Aeterna Zentaris (AEZS), Liberty Biopharma (LTY), BriaCell Therapeutics (BCT), Acasti Pharma (ACST), Reunion Neuroscience (REUN), Neptune Wellness Solutions (NEPT), Antibe Therapeutics (ATE), Sirona Biochem (SBM), and Hemostemix (HEM). These companies are all part of the "biotechnology" industry. Resverlogix vs. Devonian Health Group Aeterna Zentaris Liberty Biopharma BriaCell Therapeutics Acasti Pharma Reunion Neuroscience Neptune Wellness Solutions Antibe Therapeutics Sirona Biochem Hemostemix Devonian Health Group (CVE:GSD) and Resverlogix (TSE:RVX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, community ranking, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations. Is GSD or RVX more profitable? Resverlogix has a net margin of 0.00% compared to Devonian Health Group's net margin of -32.50%. Resverlogix's return on equity of 6.06% beat Devonian Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Devonian Health Group-32.50% -23.31% -8.12% Resverlogix N/A 6.06%-34.90% Does the media refer more to GSD or RVX? In the previous week, Devonian Health Group's average media sentiment score of 0.00 equaled Resverlogix'saverage media sentiment score. Company Overall Sentiment Devonian Health Group Neutral Resverlogix Neutral Does the MarketBeat Community favor GSD or RVX? Resverlogix received 285 more outperform votes than Devonian Health Group when rated by MarketBeat users. Likewise, 84.01% of users gave Resverlogix an outperform vote while only 65.79% of users gave Devonian Health Group an outperform vote. CompanyUnderperformOutperformDevonian Health GroupOutperform Votes2565.79% Underperform Votes1334.21% ResverlogixOutperform Votes31084.01% Underperform Votes5915.99% Which has more risk and volatility, GSD or RVX? Devonian Health Group has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Resverlogix has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Which has higher valuation and earnings, GSD or RVX? Resverlogix has lower revenue, but higher earnings than Devonian Health Group. Devonian Health Group is trading at a lower price-to-earnings ratio than Resverlogix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDevonian Health GroupC$9.75M2.74-C$3.17M-C$0.02-9.00ResverlogixN/AN/A-C$2.81M-C$0.02-1.73 SummaryResverlogix beats Devonian Health Group on 6 of the 10 factors compared between the two stocks. Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVX vs. The Competition Export to ExcelMetricResverlogixBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$6.93MC$125.51MC$5.55BC$5.71BDividend Yield7.02%3.69%5.09%6.84%P/E Ratio-1.733.2722.6828.76Price / SalesN/A4,272.59404.28583.23Price / Cash132.5013.0238.1883.20Price / Book-0.1534.206.793.77Net Income-C$2.81M-C$90.45MC$3.22BC$301.04M7 Day PerformanceN/A1.71%2.44%0.87%1 Month PerformanceN/A4.81%3.78%0.07%1 Year PerformanceN/A94.53%17.05%14.62% Resverlogix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVXResverlogixN/AC$0.04-12.5%N/A-41.7%C$6.93MN/A-1.7319Gap DownGSDDevonian Health GroupN/AC$0.18-18.2%N/A-28.0%C$26.68MC$9.75M-9.006Gap DownAEZSAeterna ZentarisN/AN/AN/AN/AC$25.37MC$2.37M-2.6120LTYLiberty BiopharmaN/AC$2.00+∞N/A+0.0%C$21.54MN/A-12.66N/AGap UpBCTBriaCell TherapeuticsN/AC$7.64+7.3%N/A+84.3%C$19.70MN/A-5.7716High Trading VolumeACSTAcasti PharmaN/AC$0.58+1.8%N/A+0.0%C$18.19MC$2.71M-1.2132REUNReunion NeuroscienceN/AN/AN/AN/AC$16.64MC$4.86M-0.43190Gap DownNEPTNeptune Wellness SolutionsN/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap DownATEAntibe TherapeuticsN/AN/AN/AN/AC$15.64MC$9.71M-0.8411SBMSirona BiochemN/AC$0.06-7.7%N/A-7.7%C$15.41MC$683,768.00-6.00N/AGap DownHigh Trading VolumeHEMHemostemixN/AC$0.10+5.6%N/A+137.5%C$13.84MN/A-2.77N/A Related Companies and Tools Related Companies Devonian Health Group Competitors Aeterna Zentaris Competitors Liberty Biopharma Competitors BriaCell Therapeutics Competitors Acasti Pharma Competitors Reunion Neuroscience Competitors Neptune Wellness Solutions Competitors Antibe Therapeutics Competitors Sirona Biochem Competitors Hemostemix Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:RVX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Resverlogix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVX Stock Free RVX Stock Alerts